Skip to main content

Table 3 Prevalence of polymorphic HML-2 proviruses in breast cancer

From: The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls

HML-2 Locus

Breast cancer casesa

Healthy controlsa

 

# Positive

Frequency

# Positive

Frequency

χ2

p-valueb

1p31.1

16

0.64

17

0.68

0.09

0.76

3q13.2

25

1.00

25

1.00

  

6q14.2

21

0.84

23

0.92

0.75

0.34

7p22.1R

25

1.00

25

1.00

  

7p22.1 L

24

0.96

25

1.00

1.02

0.31

8p23.1a

6

0.24

1

0.04

4.15

0.04*

10p12.1

24

0.96

25

1.00

1.02

0.31

11q22.1

23

0.92

20

0.80

1.49

0.22

12q13.2

20

0.80

21

0.84

0.13

0.72

12q14.1

23

0.92

22

0.88

0.22

0.67

19p12b

3

0.12

3

0.12

  
  1. aBand sizes are based on estimated fragment lengths; each has been indicated by arrow in Figure 2.
  2. bTotal sample size was 50 (n = 25 per group).
  3. *Indicates significance (p > 0.05) within the dataset (not corrected for multiple comparisons).
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us